Prime Medicine Ratios (2021-2026) | PRME

Ratios Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -7,720.30%-25,128.23%-1,936.60%-3,568.78%-4,716.68%-10,155.35%-5,671.60%-26,718.81%
EBIT Margin (Quarter) -8,179.53%-25,948.33%-2,025.74%-3,603.30%-4,787.17%-4,405.96%-5,800.48%-5,917.52%
EBITDA Margin (Quarter) -8,179.53%-25,948.33%-2,025.74%-3,603.30%-4,787.17%-4,405.96%-5,800.48%-5,917.52%
Operating Margin (Quarter) -8,179.53%-25,948.33%-2,025.74%-3,603.30%-4,787.17%-4,405.96%-5,800.48%-5,917.52%
Net Margin (Quarter) -7,742.98%-25,128.23%-1,936.60%-3,568.78%-4,716.68%-4,129.14%-5,498.69%-5,738.55%
FCF Margin (Quarter) -11,597.29%-10,429.19%696.38%-3,526.75%-3,510.13%-3,194.45%-4,480.43%-4,989.49%
Efficiency
Assets Average (Quarter) 287.79M338.63M298.91M260.00M216.50M252.62M285.54M296.24M315.15M312.84M303.59M332.01M363.87M318.73M
Asset Utilization Ratio (Quarter) 0.000.000.000.010.010.020.020.010.01
Leverage & Solvency
Interest Coverage Ratio (Quarter) -2.38-316.55-0.62-23.79-1.64-2.82-0.57-0.24-0.27-0.26-0.25-0.26-0.27-0.75-0.02M-0.28
Times Interest Earned (Quarter) -2.38-316.55-0.62-23.79-1.64-2.82-0.57-0.24-0.27-0.26-0.25-0.26-0.27-0.75-0.02M-0.28
Valuation
Enterprise Value (Quarter) -200.66M-117.74M-164.25M-92.24M-137.12M-286.09M-243.38M-126.97M-48.78M-47.03M-100.78M-158.18M-122.89M-185.47M-95.79M-57.21M-76.26M-177.68M-135.50M
Return Ratios
Return on Sales (Quarter) -0.77%-3.68%-2.51%-0.19%-0.36%-0.47%-1.02%-0.57%-2.67%
Return on Capital Employed (Quarter) -44.64%-43.42%-57.60%-79.51%-127.94%-93.39%-84.41%-87.58%-73.04%-74.14%-75.78%-68.68%-63.83%-73.15%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%